Jinyu Bio-Tech subsidiary gains new veterinary drug certificate
Jinyu Bio-Technology Co., Ltd. (SSE:600201) announced that its subsidiary, Jinyu Baoling Biological Drugs Co., Ltd., in collaboration with its holding subsidiary, Liaoning Yikang Biological Co., Ltd., has received a new veterinary drug registration certificate for its inactivated vaccine against Clostridium perfringens type A (CNM0708 strain) in cattle. The vaccine, categorized as a Class II new veterinary drug, is designed to prevent bovine sudden death syndrome caused by Clostridium perfringens type A.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when Jinyu Bio-Technology publishes news
Free account required • Unsubscribe anytime